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In rat skin, type IV is the major 3f3-hydroxysteroid dehydro-
genase/ ~5_~4 isomerase (3f3-HSD) isoenzyme expressed. Al-
though types I and II 3f3-HSD mRNAs are also present in the 
skin, their level of expression is about two orders of magni-
tude lower than that of type IV. In this study, we have inves-
tigated the control of type IV 3f3-HSD mRNA levels as well 
as 3f3-HSD enzymatic activity in hypophysectomized adult 
rats of both sexes. Skin 3f3-HSD activity was measured by the 
conversion of (14C]-dehydroepiandrosterone into [t4C]-
androstenedione, whereas ribonuclease protection assay 
using a specific type IV cRNA probe was used to assess 
mRNA levels. Intact male and female rats show a similar 
level of skin 3f3-HSD activity, although hypophysectomy 
caused opposite effects, a decrease being observed in males 
while an increase was observed in hypophysectomized fe-
male animals. We next studied the effects of hyperprolactin-
T he conversion of ils-3/3-hydroxysteroid precursors . into the corresponding il4-ketosteroids by isoenzymes of the 3f3-hydroxysteroid dehydrogenase/ ils_il4 iso-merase (3/3-HSD) family is an obligatory step in the biosynthesis of all classes of hormonal steroids [1] . 
The expression and/or activity of 3f3-HSD subtypes has been de-
scribed in all classical steroidogenic tissues, namely the adrenal cor-
tex, testis, ovary, and placenta, as well as in numerous peripheral 
target tissues including the skin, liver, fat, kidney, uterus, epididy-
mis, mammary gland, and prostate in the human and other mam-
malian species [1 - 9]. It is becoming recognized that 3f3-HSD in 
peripheral tissues plays an important role in local steroid biosynthe-
sis where it catalyses the transformation of dehydroepiandrosterone 
(DHEA) into active sex steroids, thus providing steroids that exert 
their action in the same cells which are responsible for their synthe-
sis, a new area called intracrinology [10,11]. 
Although a series of studies have addressed the role of sex steroids 
in the control of hair growth and sebaceous gland physiology, the 
importance of rat skin as a site of regulated steroid biosynthesis and 
metabolism has received little attention. Rat hair growth and se-
baceous gland activity have been shown to be modulated by pitui-
tary hormones, namely growth hormone (GH) [12), prolactin 
(PRL) [13], adrenocorticotropic hormone (ACTH) via formation of 
corticosteroids [14,15), and thyroid-stimulating hormone (TSH) 
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emia, corticosterone and I-thyroxine in hypophysectomized 
animals . L-thyroxine was found to stimulate 3f3-HSD ex-
pression and activity in male rats whereas no significant effect 
was observed on the already elevated levels in hypophysecto-
mized female rats. Corticosterone caused an inhibition of 
type IV 3f3-HSD mRNA levels and activity in both male and 
female animals . Hyperprolactinemia achieved by pituitary 
implants inserted under the kidney capsule stimulated the 
expression of type IV mRNA as well as 3f3-HSD enzymatic 
activity in hypophysectomized male and female animals. The 
present data demonstrate the multihormonal regulation of 
3f3-HSD/isomerase expression and activity in the rat skin. 
Key words; skin/3f3-HSD /steroidogenesis/intracrinology /pro lac-
tin/corticosterone/thyroid hormone/sebaceous gla nd. ] Invest Der-
matol 103;60- 64, 1994 
via thyroid hormones [16] as well as melanocyte-stimulating hor-
mone (MSH) ([17]. see [18] for review). The presence of3f3-HSD ill 
rat skin has been reported [19,20) and local rat skin steroidogenesiS 
has also been suggested to modulate sebaceous gland physiology 
(21). Following these early pioneering studies, little attention has 
been given to this subject, which was possibly awaiting the availa-
bility of the molecular biology tools recently made available [4,5J. 
SO far, in the rat, the structure of four 3f3-HSD isoenzymes has 
been described and the expression of their corresponding mRNAs 
has been characterized in many tissues [4,5,22-25]. The rat types! 
and II 3f3-HSD expressed in the adrenals, gonads, kidneys, placenta, 
and adipose tissue share 93.8% homology. The type I 3f3-HSD 
protein has a relative specificity much higher than that of the type II 
protein. On the other hand, the liver-specific type III protein, shar-
ing approximately 80% homology with the other rat isoenzymes, 
does not display the expected classical 3/3-HSD activity but is rather 
a 3-ketosteroid reductase, which catalyzes the conversion of 3-keto 
saturated steroids such as DHT into their corresponding 3p· 
hydroxy metabolite. Finally, the rat type IV 3f3-HSD shares 90.9%, 
87.9%, and 78.8% identity with that of rat types I, II, and III 3p· 
HSD proteins, respectively. The affinity and the specific activity of 
rat type IV are similar to those of the rat type I 3/3-HSD isoenzyme. 
In the skin, type IV 3P-HSD is the major mRNA species ex· 
pressed at levels at least two orders of magnitude higher than that of 
the type I and type II isoenzymes [26). The highly predominant 
expression of the type IV 3fi-HSD gene in the skin offers a unique 
opportunity to investigate the hormonal control of this newly de· 
scribed gene and to further improve our knowledge on the control 
of skin steroidogenesis. The present study investigates the effect of 
I-thyroxine or corticosterone as well as hyperprolactinemia on rat 
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skin type IV 3P-HSD mRNA levels as well as on 3P-HSD enzy-
matic activity. 
MATERIALS AND METHODS 
An- als Intact or hypophysectomized adult male and female Sprague-Da~y rats (CrI : CD(SD)Br) were purchased fron~ Charles River (St-Con-
Quebec, Canada) and housed rwo per cage m a light (14-h Ilght/d; ~~a~t, on at 0600 h) and temperature-controlled (22 ± 1 C) environment. ~t t~ntact rats received Agway ProLab R-M-H diet 4018 (Pro Lab) and 
e I ad libitul/I , whereas hypophysectomized animals received, in addition, 
water . 
es apples, and 5% glucose m 0.9% NaCI. orang , 
H rnones Corticosterone (CORT) was purchased from Steraloids (Wil-
or NH) and administered subcutaneously rwice daily in 5% ethanol, 0.9% ~~CI , 1% gelatin, and water (vehicle). L-thyroxine (T4) was from Sigma 
(St. Louis, MO) and admmlstered m a 10" N NaOH, 0.9% NaCl, 1% 
gelatin-H20 (pH 10.5). 
E rilUental Procedures Male and fema le animals were ass igned ran-
d XPfy to the following groups: a) Intact rats with 1) vehicle alone; and b) 
hom hysectomized rats with 2) vehicle alone, 3) vehicle plus pituitary i;P~;nts (PI) , 4) corticosterone (350 ,ug), and S) I-thyroxine (T4) (25 ,ug). In 
h p propriate groups, three antenor pltultanes removed from mtact female 
t e a(Pbody weight 300 to 400 g) were inserted under the left kidney capsule 
rats . I . 2 d before startmg t le expenment. 
H rnone Measurements Serum PRL was measured by double-antibody Rl~ using rat PRL-I-5 for iodination, rat PRL-RP-3 as reference pre para-
. and rabbit antiserum (anti-rPRL-S-9), kindly supplied by the National 
hIont.'tute of Diabetes and Digestive and Kidney Diseases (NIDDK). Rat 
ml . b' lb' PRL-RP-3 contams 1 % ovme serum a umm. 
RNA Isolation and Hybridization Analyses Total RNA was extracted 
from shaved d~rsal skin with an auto~ated nucleic a~id extractor (~odel 
340 Applied BlOsystems Inc. Foster City, CAl accordmg to supplter s pro-
t 'I Total RNA thus obtained was solubilized in sterile water, ethanol-~~~i~itated, and resuspended in sterile water. Poly A+ RNA was purified 
p 'ng oligo-dT cellulose chromatography [27]. Samples of rat skin polyA+ ~A (4 ;,tg) were hybridized to a specific type IV cRNA probe (284 bp) [26] 
and then digested With nbonucleases A and T1. The protected fragments 
(157 bp) were resolved on a denaturing polyacrylamide-urea sequencing gel 
as previously described [4,5]. Signals were detected and quantified with a 
PhosphorImager (Molecular Dynamics, Sunnyvale, CAl. Results are ex-
pressed as mean ± SEM (n = 3-4) in arbitrary units (control groups were set 
at 100). 
Enzymatic Assay of3P-HSD Activity Assays of 3/1-HSD activity were 
performed as previously described [28-31]. Briefly, pieces of dorsal skin 
(about 1 g) were homogenized in 2 ml of phosphate buffer (pH 7.5) con-
taining protease. inhibitors and centrifuged for 30. min at 1000 X g. One 
hundred microltters of the supernatant were then mcubated for 45 mm at 
37°C in a total volume of 0.5 ml phosphate buffer containing 0.75,uM 
[14c]_dehydroepiandrosterone (DHEA) and 0.8 luM NAD+. Labeled 
DHEA (51 mCi/mmol) was from DuPont (Markham, Canada) and purified 
by thin-layer chromatography (TLC) before use as previously described [29]. 
The enzymatic reaction was stopped by chilling the incubation mixture in an 
ice-water slurry and adding 3 ml of diethyl ether and mixing. The compo-
nents were then frozen in a dry ice-ethanol bath. The liquid organic phase 
was kept while the frozen aqueous fraction was reextracted once with ether. 
The organic phases were then pooled and evaporated to dryness under a 
nitrogen stream. The [14C]-64-dione produced from [14C]-DHEA was then 
separated on TLC before autoradiography for 2 d. The TLC areas corre-
sponding to DHEA and 6 4-dione were cut and transferred into vials con-
taining 0.5 ml ethanol and 10 ml of scintillation liquid was added. The 
radioactivity was then measured. Protein content was measured by the 
method of Bradford [32]. Results are expressed as means ± SEM (n = 9) in 
pmoles of androstenedione (D,4-dione) formed/mg protein/min. 
Statistical Analysis Statistical significance was determined according to 
the multiple-range test of Duncan-Kramer [33]. 
RESULTS 
The level of rat skin 3P-HSD activity measured by the conversion of 
[14C]-DHEA into [1 4C]-~4-dione is comparable in male and female 
intact animals (4.71 ± 0.53 pmoles of p4C]-~4-dione formedjmg 
protein/min versus 4.04 ± 0.38 pmoles) . Hypophysectomy, how-
ever, had opposite effects on this parameter in animals of the two 
sexes: thus, although in male rats hypophysectomy caused a 34% 
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Figure 1. Effect of prolactin on 3/1-HSD expression. Ribonuclease protec-
tion analysis of the effect of hyperproiactinemia achieved by pituitary grafts 
(PI) under the kidney capsule on type IV 3/1-HSD mRNA levels in the skin 
of hypophysectomized male and female rats . Control arUmals (CO NT) and 
animals bearing three pituitary grafts each received the vehicle for 9 d 
starting 15 d after surgery. Samples of rat skin poly A+ RNA (4,ug) were 
hybridized to a specific type IV cRNA probe (284 bp) and then digested with 
ribonucleases as described in Materials al/d Methods. The protected fragments 
(157 bp) were resolved on a denaturing polyacrylamide-urea sequencing gel 
as previously described [4,5]. Signals were detected with a phosphorlmager. 
(p < 0 .01) decrease in 3/l-HSD activity, it induced a 40% stimula-
tion (p < 0.05) of the same parameter in female rats. 
As shown in Fig 1, with 4 IJ.g of male hypophysectomized rat skin 
poly A + RNA the expected protected fragment of 157 nucleotides 
is detected after ribonuclease digestion, and hyperprolactinemia 
achieved by pituitary implants (PI) caused a marked increase in type 
IV mRNA levels. Similarly, in female skin, PI increased type IV 
3/l-HSD mRNA levels. Signals of the 157 l1ucleotides-protected 
fragment were quantified, and results are represented in Fig 2A in 
arbitrary units. It can be seen that pituitary implants had a stimula-
tory effect on type IV 3P-HSD mRNA levels in hypophysecto-
mized male skin as well as female skin. In male rats, mRNA levels 
were increased by 3.4 times (p < 0.01) over hypox controls, 
whereas in female rats the same treatment caused a 2-times (p < 
0.01) increase. Pituitary implants (PI) grafted under the kidney 
capsule raised serum PRL in hypophysectomized rats to levels about 
4.5 (female) and 7 (male) times higher than those measured in intact 
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Figure 2. Effect of prolactin on 3P-HSD activity. Effect of hyper prolactin-
emia achieved by pituitaty grafts (PI) on 3P-HSD mRNA levels (A) and 
enzymatic activity (B) in hypophysectomized male and female rats. Animals 
were treated as described in the legend to Fig 1. Signals corresponding to the 
157 nucleotide protected fragments were quantified with a phosphor-
Imager and 3p-mRNA levels are expressed in arbitrary units (control groups 
set at 100) as means ± SEM (n = 3-4). Skin homogenates were incubated 
with 0.75 /lM of [14C]-DHEA and 0.8 mM NAD+ as described in Materials 
and Methods. The data are presented as means ± SEM of nine independent 
derterminations of skin 3P-HSD activity expressed in pmoles of ,1.4-dione 
formed/mg protein/min. " p < 0.01 versus control group. 
control animals (data not shown). In addition to the changes in 
3P-HSD mRNA levels, hyperprolactinemia caused a highly signifi-
cant stimulation of 3P-HSD activity in both male and female hy-
pophysectomized animals (Fig 2B). In fact, in the male hypohysec-
tomized rat, skin 3P-HSD enzymatic activity was increased to levels 
1.2 times (p < 0.01) above those of hypox animals, whereas in the 
female the levels achieved were 50% above those achieved by hy-
pophysectomy (p < 0.01) . 
We next investigated the effect of treatment with CORT and 
T4 on the same parameters in hypophysectomized animals. As ob-
served in Fig 3, CORT (350 /lg, twice daily) clearly inhibited type 
IV 3P-HSD mRNA levels in both male and female hypox animals, 
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Figure 3. Effect of glucocorticoid and thyroid hormones on 3P-HSD ex-
pression. Ribonuclease protection analysis of the effect of treatment with 
corticosterone (COR) or I-thyroxine (T4) on type IV 3P-HSD mRNA levels 
in the skin of hypophysectomized male and female rats. Corticosterone 
(COR, 350 /lg) and T4 (25 /lg) were administered twice daily for a period of 
9 d starting 15 d after hypophysectomy. Hypophysectomized control ani-
mals (C) received the vehicle alone for 9 d. Samples were processed as 
described in legend to Fig 1. 
whereas T4 (25 J1g, twice daily) stimulated this parameter only in 
male rats. In fact, as shown in Fig 4A, CORT decreased type IV 
3P-HSD mRNA levels by 31% (p < 0.05) in male and 53% (p < 
0.01) in female rats compared to the corresponding hypox control 
groups. 
On the other hand, T4 stimulated 3P-HSD mRNA levels in male 
animals 50% over hypox controls (p < 0.05) , whereas no effect was 
observed in female animals. Similarly, as shown in Fig 4B, T4 
caused a 60% increase of skin 3P-HSD activity in hypox male ani-
mals, whereas no effect was observed in female animals. Corticos-
terone (350 J1g, twice daily) caused a 38% decrease (p < 0.01) in 
female-skin 3P-HSD activity, whereas at this dose no effect was 
observed in male animals. However, at a higher dose (1.5 mg), 
CORT decreased significantly male-skin 3P-HSD activity to levels 
observed in female animals (data not shown). 
DISCUSSION 
Our data show clearly that the type IV 3P-HSD gene specifically 
expressed in rat skin is regulated by the pituitary hormone PRL as 
well as by thyroid and glucocorticoid hormones. Considering that 
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Figure 4. Effect of glucocorticoid and thyroid hormones on 3P-HSD activ-
ity. Effect of corticosterone (CORT) or thyroxine (T4) on 3P-HSD mRNA 
levels (A) and enzymatic activity (B) in the skin of hypophysectomized male 
and female rats . Animals were treated as described in the legend to Fig 3 and 
samples processed as described in legend to Fig 2. The mRNA levels are 
expressed in arbitrary units (control groups set at 100) as means ± SEM of 
3-4 independent determinations. Three P-HSD activity is presented in 
pmoles of ~'-dione formed mg protein/min as means ± SEM of nine inde-
pendent determinations.·p < 0.05, "p < 0.01 versus hypox control group. 
the skin is the largest organ in the body, 3fi-HSD could play an 
important role, not only in skin physiology, but also in the global 
steroid formation of the whole animal. Interestingly, sexual dimor-
phism was observed for skin 3fi-HSD in response to various hor-
monal manipulations. Pituitary removal stimulates female skin 3fi-
HSD activity, whereas it inhibits the same parameter in male 
animals. This phenomenon could be partly explained by the obser-
vation that androgens stimulate 3fi-HSD activity in male rat skin, 
whereas estrogens inhibit this parameter in females (unpublished 
data). Thus, following hypophysectomy, the sex-specific decrease 
in steroid formation by the gonads could modulate skin 3fi-HSD 
activity. In addition, T4 stimulates skin 3fi-HSD activity and ex-
pression only in male hypohysectomized animals, whereas CORT, 
at physiologic doses, shows inhibitory effects on skin activity only 
in female rats. The levels of3fi-HSD enzymatic activity were, how-
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ever, reduced by high doses of CORT in animals of both sexes (data 
not shown). On the other hand, hyperprolactinemia stimulated 
both male and female skin 3fi-HSD type IV mRNA levels and 
activity. 
The most significant sex dimorphism was the one observed fol-
lowing hypophysectomy. In fact, the increase in 3fi-HSD activity 
observed following hypophysectomy in female animals could ex-
plain the lack of significant stimulatory effect of treatment with 
thyroid hormones in female animals because maximal or near-max-
imallevels of3fi-HSD activity could have been reached by hypophy-
sectomy alone. However, the reduced levels of3fi-HSD in hypoph-
ysectomized male rats might explain the absence of significant 
inhibitory effects of a physiologic dose of CORT [34] in hypophy-
sectomized male animals, whereas a clear inhibitory effect is ob-
served on the elevated levels of hypophysectomized female rats. 
Three fi-HSD genes (type I, II, and IV) are expressed in the rat 
skin, although expression of the type IV gene is at least 100 times 
higher than that of types I and II [26]. We have observed in other 
studies (Martel et aI, unpublished data) opposite effects of PRL, 
thyroid hormone, and CORT on3fi-HSD enzymatic activity in rat 
skin and kidney. Since type I and II 3fi-HSDs are the genes predom-
inantly expressed in the kidney, the opposite effects of PRL, 
CORT, and thyroid hormones in these two tissues could indicate 
not only specificity of expression of the various 3fi-HSD genes in 
the skin and kidney, but also specific hormonal regulation in these 
two tissues. The effect of hypophysectomy on 3fi-HSD activity is 
also different in the kidney (Martel et ai, unpublished data). Such 
observations suggest differences in the promoter areas of the various 
3fi-HSD genes and/or tissue-specific expression and activity of reg-
ulatory proteins. 
L-thyroxine reversed the inhibition induced by hypophysectomy 
on male skin 3fi-HSD /isomerase activity and expression, whereas 
female skin 3fi-HSD activity and expression remained unchanged 
after the same treatment. Although the effects of thyroid hormones 
have been extensively studied on hair growth, no data were yet 
av.ailable on the effect of thyroid hormones on rat skin steroidogen-
eSIs. 
Hyperprolactinemia achieved by pituitary grafts implanted under 
the kidney capsule succeeded in stimulating female skin 3fi-HSD 
activity and type IV mRNA expression but to a lower extent than in 
male animals. It is interesting to observe the relatively low sensitiv-
ity of female skin 3fi-HSD to prolactin compared to that of male 
animals. Similar conclusions were reached for the effect of prolactin 
in the female kidney although an opposite effect was observed 
(Martel et ai, unpublished data). 
Corticosterone at the physiologic dose used (350 J1.g, twice daily) 
[34] decreased skin 3fi-HSD in female hypophysectomized rats but 
not male. When a higher dose (1.5 mg, twice daily) was given to 
hypox male animals, comparable inhibitory effects were observed in 
the male and female animals. It is of interest to observe that the 
opposite situation compared to prolactin treatment is found in re-
sponse to corticosterone. In fact, male skin 3fi-HSD activity was less 
responsive to the glucocorticoid than that of female skin. 
In summary, our data demonstrate that skin 3fi-HSD is regulated 
by different hormon~s . W~ereas hypophysectomy caused opposite 
effects, the effect bel11g stimulatory on skin 3fi-HSD activity in 
female and inhibitory in male rats, T4 and prolactin had stimulatory 
effects, and corticosterone was inhibitory. Such data suggest that the 
skin might well be an important site of steroid formation under 
stringent control by pituitary and sex hormones. 
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INTERNATIONAL RESEARCH WORKSHOP ON ALOPECIA AREATA 
The Second International Research Workshop on Alopecia Areata will be held on November 7 
and 8, 1994. The two-day workshop will bring together investigators for an open exchange of 
recent advances in alopecia areata, as well as studies of hair follicle biology. Topics will include 
immunogenetics, target tissues, dermal-epidermal instructions, stem cells, growth factors, and 
animal models. Results of this workshop will guide further research in this field. 
The workshop is co-sponsored by the N ational Alopecia Areata Foundation (NAAF) and the 
N ational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and will be held 
at the Lister Hill Auditorium on the campus of the N ational Institutes of Health (NIH) in 
Bethesda, MD. For more information call the NAAF office at (415) 456-4644. 
